BESSOR PHARMA, LLC
BP-1002, a 36-amino acid renalase agonist peptide therapeutic for COVID-19 and inflammatory diseases
- Sector
- Biotech
- Headquarters
- Framingham, MA
- Total capital
- $6.1M
- Federal grants
- $6.1M
- 9 awards · 2016–2025
- Rank in peer group#90 of 514
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 9 pending · first 2022
- Rank in peer group#85 of 514
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Development of a novel renalase agonist for the treatment of acute pancreatitis$904K
- Federal grantHealth and Human S · Phase I · New target and new therapy for severe Covid-19 and viral hyperinflammation damage: renalase and renalase agonists$297K
- Federal grantHealth and Human S · Phase I · New target and new therapy for severe Covid-19 and viral hyperinflammation damage: renalase and renalase agonists$300K
- Federal grantHealth and Human S · Phase II · Novel Target, New Therapy: Anti- Renalase Antibody for Tumors Resistant to PD-1Inhibitors$672K
- Federal grantHealth and Human S · Phase II · Novel Target, New Therapy: Anti- Renalase Antibody for Tumors Resistant to PD-1Inhibitors$1.3M
- Federal grantHealth and Human S · Phase II · Renalase: Development as an Innovative New Drug for Acute Pancreatitis$1.1M
- Federal grantHealth and Human S · Phase II · Renalase: Development as an Innovative New Drug for Acute Pancreatitis$849K
Show 2 earlier federal awards
- Federal grantHealth and Human S · Phase I · Humanized Anti-Renalase Antibodies for Unresectable Melanoma$300K
- Federal grantHealth and Human S · Phase I · Acute Pancreatitis: Renalase as a novel target and agonists as new therapy$300K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grants#90 · top 18%
- Granted patents#85 · top 17%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 4 granted of 13- GrantedApplications of Known and Novel CannabinoidsUSPTOUS 12,252,477
- PendingProcess for the Production of Cannabinoids and Cannabinoid AcidsUSPTOApplication 17767760
- GrantedSynthetic Intermediates for Novel Cannabinoids and Cannabinoid Acids and Their DerivativesUSPTOUS 11,685,724
Show all 13 patent records
- Applications of Known and Novel CannabinoidsMar 18, 2025 · US 12,252,477Granted
- Process for the Production of Cannabinoids and Cannabinoid AcidsMar 28, 2024 · Application 17767760Pending
- Synthetic Intermediates for Novel Cannabinoids and Cannabinoid Acids and Their DerivativesJun 27, 2023 · US 11,685,724Granted
- Process for the Production of CannabinoidsAug 9, 2022 · US 11,407,724Granted
- Novel Cannabinoids and Cannabinoid Acids and Their DerivativesJun 28, 2022 · US 11,370,768Granted
- Stable Peptides Having Renalase Agonist ActivityApplication 63032055Pending
- Applications Of Known And Novel CannabinoidsApplication PCTUS2019047284Pending
- Analogs of Cannabichromene and Cannabichromenic Acid and Process of PreparingApplication 19164863Pending
- Novel Cannabinoids And Cannabinoid Acids And Their DerivativesApplication PCTUS2019047280Pending
- Analogs Of Cannabichromene And Cannabichromenic Acid And Process Of PreparingApplication PCTUS2024020086Pending
- Process For The Production Of Cannabinol, Cannabinolic Acid, Cannabivarin, Cannabivarinic Acid And Related CannabinoidsApplication PCTUS2021052844Pending
- Stable Peptides Having Renalase Agonist ActivityApplication PCTUS2021034706Pending
- Process For The Production Of Cannabinoids And Cannabinoid AcidsApplication PCTUS2020054525Pending
Related companies, and why
- Otzi Bio LLCSimilar federal contract value in Biotech · null in contracts
- Promentis PharmaceuticalsSimilar federal contract value in Biotech · null in contracts
- SABER THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- ONCOSTING LLCSimilar federal contract value in Biotech · null in contracts
- SPYRYX LLCSimilar federal contract value in Biotech · null in contracts
- IONTX INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .